|
|
|
|
|
|
Ascendis Pharma Ads (ASND)
|
|
27.90 -0.10 (-0.36%)
|
8/18/2017 4:00pm
|
|
Open:
|
N/A
|
Pre. Close:
|
28.00
|
|
High:
|
28.03
|
Low:
|
27.00
|
|
Volume:
|
38,685
|
Market Cap:
|
N/A
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
28.45 - 28.63
|
28.63 - 28.87
|
|
Low:
|
25.75 - 26.12
|
26.12 - 26.61
|
|
Close:
|
27.11 - 27.69
|
27.69 - 28.43
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-18 4:35:04 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 33.01 One year: 34.33
|
|
Support:
|
Support1: 26.43 Support2: 21.99
|
|
Resistance:
|
Resistance1:
28.26 Resistance2: 29.39
|
|
Pivot:
|
27.79
|
|
Moving Averages:
|
MA(5): 27.80  MA(20): 27.82
MA(100): 26.94 MA(250): 23.94
|
|
MACD:
|
MACD(12,26):
0.13 Signal(12,26,9): 0.19
|
|
%K %D:
|
%K(14,3): 58.57 %D(3): 56.93
|
|
RSI:
|
RSI(14): 53.61
|
|
52-Week:
|
High: 31.86
Low: 17.15 Change(%): 54.8
|
|
Average Vol(K):
|
3-Month: 9736
10-Days 2026
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ASND has closed below upper band by 42.0%. Bollinger Bands are 57.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ASND's normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Fri, 18 Aug 2017 10:52:30 GMT
Ascendis Pharma A/S Reports Second Quarter 2017 Financial Results
Fri, 31 Mar 2017 09:57:12 GMT
Ascendis Pharma A/S Announces Updated Time for April 3 Conference Call to ...
Tue, 23 May 2017 20:03:36 GMT
Ascendis Pharma A/S Reports First Quarter 2017 Financial Results
Thu, 23 Mar 2017 13:04:20 GMT
Ascendis Pharma A/S Announces Conference Call and Webcast to Review Data at ...
Mon, 04 Apr 2016 11:02:47 GMT
Ascendis Pharma A/S Announces TransCon Growth Hormone Oral and Poster ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
